Cita APA (7a ed.)

Formisano, L., Lu, Y., Servetto, A., Hanker, A. B., Jansen, V. M., Bauer, J. A., . . . Arteaga, C. L. (2019). Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer. Nature Portfolio.

Cita Chicago Style (17a ed.)

Formisano, Luigi, et al. Aberrant FGFR Signaling Mediates Resistance to CDK4/6 Inhibitors in ER+ Breast Cancer. Nature Portfolio, 2019.

Cita MLA (8a ed.)

Formisano, Luigi, et al. Aberrant FGFR Signaling Mediates Resistance to CDK4/6 Inhibitors in ER+ Breast Cancer. Nature Portfolio, 2019.